Page results
-
Health and wellbeing information for people affected by cancer.
-
This information aims to support and supplement the information provided in the Be Active video available on uclh.nhs.uk/wellbeing
-
Once again, UCLH has received the highest score of all general acute and acute/community NHS trusts in England for staff that would recommend us as a place to work
-
This information explains when planned caesareans would be provided at The Whittington Hospital for women having antenatal care at UCLH.
-
Patient information on managing pain
-
This page provides information about ERCP (Endoscopic Retrograde Cholangiopancreatography) procedure.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
Information about clinic-based after-care following treatment for childhood or teenage cancer at UCLH.
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
Events, classes and workshops at the Macmillan Support and Information Service (MSIS)
File results
-
FOI/2023/0706 - Child immunisation service/ screening and immunisation teams
-
FOI/2023/0708 - Private Patient Unit (PPU) systems
-
FOI/2023/0710 - Number of substantive consultants/ clinical academics at Trust
-
FOI/2023/0712 - Nerve Unit referrals/ operations
-
FOI/2023/0713 - Administration of medicines policies
-
FOI/2023/0776 - Electronic Patients Records System (EPRS)
-
FOI/2023/0787 - HIMSS INFRAM assessment/ digital strategy
-
FOI/2023/0777 - Number of patients treated for scurvy and ricketts
-
FOI/2023/0788 - Networking/ WiFi/ telephony hardware/ unified communications refresh
-
FOI/2023/0769 - Patients with Inflammatory Bowel Disease/ Small Intestinal Bacterial Overgrowth (SIBO)